WebFeb 17, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle … Web1 day ago · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company...
With VA - Veterans Affairs
WebMar 20, 2024 · 14 Mar 2024 Cytokinetics plans a phase III MAPLE-HCM trial for Hypertrophic cardiomyopathy (In adults, In elderly) (PO) (NCT05767346) 07 Mar 2024 Updated safety and efficacy data from the phase II FOREST-HCM OLE trial in Hypertrophic cardiomyopathy presented at the American College of Cardiology 72nd Annual Scientific … WebSTOCK QUOTE Cytokinetics, Inc. INVESTORS & MEDIA STOCK QUOTE Stock Quote Stock Chart Historical Price Lookup Data Provided by Refinitiv. Minimum 15 minutes delayed. Mar 31 2024 11:06 pm EDT … bisson fondation
Cytokinetics and JI XING Announce Expansion of
WebAnalysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Ligand Pharma (LGND) and Apollo Endosurgery (APEN) March 31, 2024TipRanks. Cytokinetics says … WebJul 19, 2024 · An experimental drug being developed by South San Francisco-based biotech Cytokinetics improved cardiac function in a mid-stage clinical trial of several dozen patients with a type of heart disease, the company said Monday. Treatment with Cytokinetics' drug, called CK-274, led to significant improvements in blood flow from the heart compared to ... WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in … bisson ford bassano